Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenström’s macroglobulinemia with severe pancytopenia

Bone Marrow Transplantation

Volumn 28, Issue 6, 2001, Pages 609-611

  Ueda, T ^a   Hatanaka, K ^a   Kosugi, S ^a   Kishino, B I ^a   Tamaki, T ^a  

^a Department of Cardiology   (Japan)

Author keywords

Allogeneic PBSCT; Non myeloablative; Waldenstr m s macroglobulinemia

Indexed keywords

ALPHA INTERFERON; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; MELPHALAN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHIMERA; CONVALESCENCE; DISEASE SEVERITY; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE TRANSFUSION; MALE; MULTIDRUG RESISTANCE; PANCYTOPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYMPTOM; TANDEM REPEAT; WALDENSTROEM MACROGLOBULINEMIA;

CRITICAL ILLNESS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PANCYTOPENIA; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WALDENSTROM MACROGLOBULINEMIA;

EID: 0034769845     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703190     Document Type: Article

References (8)

1. High-dose therapy with autologous haemopoietic stem cell support for Waldenström’s Macroglobulinemia
2. Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström’s macroglobulinaemia
3. Autologous peripheral blood stem cell transplantation for Waldenström’s macroglobulinemia
4. Allogeneic bone marrow transplantation for advanced Waldenström’s macroglobulinemia
5. Mini-allografts: Ongoing trials in humans
6. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies
7. Non myeloablative conditioning with fludarabine/melphalan (FM) for patients with multiple myeloma (MM)
8. Waldenström’s macroglobulinemia: Clinical features, complications, and management